If you have a question about EMS education about how to succeed as a student, how to polish your skills as an instructor or how to push education to the next level JEMS.com education expert Paul Werfel has got an answer for you. Contact him at firstname.lastname@example.org.
I go to a couple of EMS conferences a year and try to stay on top of the changes in the profession. In my state, EMT-Basics can give inhaled medications for asthma, but I read and hear that in certain areas EMT-Bs may soon be giving naloxone to opiate overdoses.
I spoke to our service medical director and he says that he is 100% against that practice. What is the problem with the naloxone? The medics here say it is safer than the nebulizers that we are using for asthma patients. What gives?
To be honest, the use of inhalers by EMT-Bs (and some medics, I may add) has not been exactly a cakewalk. I cannot tell you how many times I have responded to asthmatics that were being treated by my colleagues with inhalers and found the patient less than conscious, while the crew member told me that the inhaler kept "falling out of his mouth" or the patient was "noncompliant."
I have then had to remind said individuals that change in mental status is a cardinal sign of respiratory failure and the patient needs to be ventilated and perhaps intubated. The inhaled asthma meds need to get to the lungs for them to work.
In this time of lawsuits involving drugs such as Vioxx and Celebrex, it is important to remember that there is no safe medication. By virtue of the fact that they interfere with normal bodily functions, each and every medication can be considered a poison. All medications cause side effects (predictable issues) or idiosyncratic reactions (totally unpredictable).
Bearing this in mind, the use of naloxone, either by IV administration or intranasal misting, carries with it the possibility of complications, side effects or idiosyncratic reactions.
Some of these may be beyond the ability of EMT-Bs to handle. Probably the most worrisome side effect of the use of naloxone is pulmonary edema. Naloxone has long been thought to be completely safe (I have included some studies below that may change some minds).
The problem is that pulmonary edema is a difficult issue to deal with for ALS providers, and probably cannot be managed adequately by most BLS crews. The opinion of the medical director may be that, since the cause of death in narcotic overdoses is respiratory arrest, simply having EMT-Bs concentrate on performing good ventilations with supplemental oxygen helps the patient and avoids the issue of post naloxone pulmonary edema.
Till next time...
Schwartz JA, Koenigsberg MD: "Naloxone-induced pulmonary edema." Ann Emerg Med. 6(11):1294 1296, 1987.
Abstract: We present the case of a 68-year-old woman with acute pulmonary edema secondary to the administration of naloxone to reverse an inadvertent narcotic overdose. The patient presented following a 12-hour history of increasingly bizarre behavior and confusion. A total IV dose of 1.6 mg naloxone was administered in an attempt to reverse the suspected overconsumption of a codeine-containing cough suppressant. She immediately became agitated, tachycardic, and diaphoretic; a clinical diagnosis of acute pulmonary edema was made. Following treatment with furosemide, nitroglycerin, and morphine sulfate, the patient recovered completely without further incident. Although naloxone is thought to be a safe drug with few complications, it should not be used indiscriminately, and the smallest doses necessary to elicit the desired response should be used.
Wei-Shu Wang, Tzeon-Jye Chiou, Ruey-Kuen Hsieh, et al: "Lethal acute pulmonary edema following intravenous naloxone in a patient received unrelated bone marrow transplantation." Chin Med J (Taipei). 60:219 223, 1997.
Abstract: A 39-year-old man was diagnosed as having acute myeloid leukemia and received 6 courses of chemotherapy. The bone marrow revealed complete remission. He had no prior history of cardiac or pulmonary disease. HLA-matched unrelated bone marrow transplantation (BMT) was performed in September 1995. Pre-transplant studies including chest X-ray, electrocardiogram and pulmonary function test were normal. The procedure of BMT was smooth and serial bone marrow examination showed successful engraftment. Serial chest X-rays done every week after BMT were normal. There were no evidence of fluid overload but severe mucositis was noted. On the 38th day after BMT, intravenous injection of 10mg morphine was prescribed to relief severe oral pain. Respiratory depression developed right after, and naloxone 0.4mg was given by an intravenous route. One hour later, severe shortness of breath was noted and the emergent chest X-ray revealed acute pulmonary edema. He became unconscious 2 hours later and expired 24 hours after naloxone injection in spite of intensive medical treatment.
Naloxone-induced acute pulmonary edema is an extremely rare but lethal complication. Only a few cases have been reported in English literature. We report a case of acute myeloid leukemia receiving unrelated BMT to develop acute pulmonary edema rapidly after intravenous injection of naloxone. The clinical features and pathogenesis are discussed.
Brimacombe J, Archdeacon J, Newell S, et al: "Two cases of naloxone-induced pulmonary edema: The possible use of phentolamine in management." Anaesth Intensive Care. 19(4):578 580, 1991.
Flacke JW, Flacke WE, Williams GD: "Acute pulmonary edema following naloxone reversal of high-dose morphine anesthesia." Anesthesiology. 47(4):376 378, 1977.
Partridge BL, Ward CF: "Pulmonary edema following low-dose naloxone administration." Anesthesiology. 65:709 710, 1986.
Stadnyk A, Grossman RF: "Nalbuphine-induced pulmonary edema." Chest. 90:773 774, 1986.
Prough DS, Roy R, Bumgarner J, et al: "Acute pulmonary edema in healthy teenagers following conservative doses of intravenous naloxone." Anesthesiology. 60:485 486, 1984.
Taff RH: "Pulmonary edema following naloxone administration in a patient without heart disease." Anesthesiology. 59:576 577, 1983.